Zijian Tian

Zijian Tian

Auto-generated profile, based on publicly available information

Zijian Tian

National Laboratory of Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences 2 , Beijing, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 October 2021 in Journal of Diabetes Research
Verified
Journal Article
Open access
PDF file
YPYing Pan
Ying Pan
SZShao Zhong
Shao Zhong
KZKaixin Zhou
Kaixin Zhou
ZTZijian Tian
Zijian Tian
FCFei Chen
Fei Chen
JHJi Hu
Ji Hu
Background. Triglyceride-glucose (TyG) index is a convenient indicator of insulin resistance. It has been shown to be associated with macrovascular and microvascular complications in nonhospitalized diabetic patients. However, whether TyG index is a risk factor of diabetes vascular complications in hospitalized type 2 diabetic patients is unclear. We sought to explore the association between TyG index and the risk of macrovascular and microvascular complications in a large Chinese cohort of hospitalized patients. Method. A total of 4,721 patients with type 2 diabetes (T2D) who were hospitalized in the Department of Endocrinology, Kunshan Hospital Affiliated to Jiangsu University were enrolled between January 2015 and November 2020. TyG index was calculated as . Measures of macrovascular complications included brachial-ankle pulse wave velocity (ba-PWV) and ankle-brachial index (ABI), whilst urine microalbumin (MAU), chronic kidney disease (CKD), and diabetic retinopathy (DR) were evaluated for microvascular complications. Logistic regressions were used to examine the association between TyG index and diabetes complications. Results. In univariate logistic regressions, higher TyG index was significantly ( ) associated with increased odds of MAU ( , 95% CI: [1.22~1.59]) and ABI ( , 95% CI: [1.10-1.57]) but not CKD, DR, or ba-PWV. After controlling for confounders such as age, sex, and body mass index (BMI), TyG index remained strongly (

23 February 2023 in Precision Clinical Medicine
Verified
Journal Article
Open access
PDF file
ZTZijian Tian
Zijian Tian
FCFei Chen
Fei Chen
JWJing Wang
Jing Wang
BWBenrui Wu
Benrui Wu
JSJian Shao
Jian Shao
KZKaixin Zhou
Kaixin Zhou
Background: Chronic diseases are becoming a critical challenge to the aging Chinese population. Biobanks with extensive genomic and environmental data offer opportunities to elucidate the complex gene–environment interactions underlying their aetiology. Genome-wide genotyping array remains an efficient approach for large-scale genomic data collection. However, most commercial arrays have reduced performance for biobanking in the Chinese population. Materials and methods: Deep whole-genome sequencing data from 2 641 Chinese individuals were used as a reference to develop the CAS array, a custom-designed genotyping array for precision medicine. Evaluation of the array was performed by comparing data from 384 individuals assayed both by the array and whole-genome sequencing. Validation of its mitochondrial copy number estimating capacity was conducted by examining its association with established covariates among 10 162 Chinese elderly. Results: The CAS Array adopts the proven Axiom technology and is restricted to 652 429 single-nucleotide polymorphism (SNP) markers. Its call rate of 99.79% and concordance rate of 99.89% are both higher than for commercial arrays. Its imputation-based genome coverage reached 98.3% for common SNPs and 63.0% for low-frequency SNPs, both comparable to commercial arrays with larger SNP capacity. After validating its mitochondrial copy number estimates, we developed a publicly available software tool to facilitate the array utility. Conclusion: Based on recent advances in genomic science, we designed and implemented a high-throughput and low-cost genotyping array. It is more cost-effective than commercial arrays for large-scale Chinese biobanking.

5 September 2023 in Clinical Pharmacology & Therapeutics
Verified
Journal Article
Closed access
PWPeng Wu
Peng Wu
ZLZiqing Liu
Ziqing Liu
ZTZijian Tian
Zijian Tian
BWBenrui Wu
Benrui Wu
JSJian Shao
Jian Shao
KZKaixin Zhou
Kaixin Zhou

16 March 2026 in Diabetes Care
Verified
Journal Article
Open access
PDF file
XHXinhao Huang
Xinhao Huang
ZTZijian Tian
Zijian Tian
YPYing Pan
Ying Pan
JZJia Zhang
Jia Zhang
BWBenrui Wu
Benrui Wu
KZKaixin Zhou
Kaixin Zhou
OBJECTIVE: mtDNA copy number (CN) reflects mitochondrial function, but prior studies have reported inconsistent associations with type 2 diabetes risk, ranging from inverse to positive or null findings. We hypothesized that mtDNA-CN is nonlinearly associated with incident type 2 diabetes. RESEARCH DESIGN AND METHODS: We included 34,835 adults without diabetes from the Kunshan Aging Research With E-Health (KARE) cohort and 289,338 from the UK Biobank (UKB). Associations between blood mtDNA-CN and incident type 2 diabetes were evaluated using Cox proportional hazards and restricted cubic spline models stratified by age. RESULTS: A U-shaped association was observed in the KARE cohort (P < 0.001), in which the hazard ratios (95% CIs) across increasing mtDNA-CN quartiles were 1.00 (reference), 0.94 (0.88–1.00), 0.85 (0.79–0.91), and 0.93 (0.87–1.00). In contrast, the UKB cohort exhibited a predominantly inverse linear trend. Age-stratified analyses revealed that this U-shaped association was particularly evident in younger participants (aged <65 years in KARE and <50 years in UKB), indicating elevated diabetes risk at both low and high mtDNA-CN levels. Additionally, mtDNA-CN declined with age in both cohorts, with an accelerated decrease beyond ∼65 years in KARE and ∼50 years in UKB. CONCLUSIONS: Blood mtDNA-CN showed a U-shaped association with incident type 2 diabetes in younger individuals.